BC Decker will be moving premises on Friday July 30th, 2010. There will be some interruption to service as we move our servers and phones. We apologize for any inconvenience this may cause and plan to work as quickly as possible to have our services back up and running as soon as possible. Thank-you.
    FEEDBACK     HELP
WELCOME: Not Logged In HOME | MY ACCOUNT | ABOUT US | CONTACT US
SEARCH
ADVANCED
 SHOP OUR CATALOG
 JOURNALS
 BCDECKER WEB SITES >
 REGISTRATION
 FREE EMAIL TOC
 AUTHOR INFORMATION >
 FAQS
 CONFERENCES
 PERMISSION GUIDELINES
 SHIPPING INFORMATION
 PRIVACY POLICY
 ADVERTISERS INFORMATION >
 PHARMA SALES >
 DISTRIBUTION PARTNERS
 
 
LOGIN
USERNAME:
PASSWORD:

SAVE PASSWORD
Forgot My password?
Register
 
External Access > PubMed LinkOut
ISSN Number: 1046-199x
Title: Dermatitis
Volume Number: 19
Issue Number: 06
Page Number: 308
Published: 4 time(s) per Year
ISSN Number: 1710-3568
Title: Dermatitis
Volume Number: 21
Issue Number:
Page Number:
Published: 6 time(s) per Year

Novel Antibacterial and Emollient Effects of Coconut and Virgin Olive Oils in Adult Atopic Dermatitis

BACKGROUND:Atopic dermatitis (AD) skin is dry and readily colonized by Staphylococcus aureus (SA). Coconut and olive oils are traditionally used to moisturize and treat skin infections.OBJECTIVE:To compare virgin coconut oil (VCO) and virgin olive oil (VOO) in moisturizing dryness and removing SA from colonized AD skin.METHODS: This was a double-blind controlled trial in two outpatient dermatology clinics with adult AD patients who were diagnosed by history, pattern, evolution, and skin lesions and who were randomized to apply VCO or VOO twice daily at two noninfected sites. SA cultures, photography, and objective-SCORAD severity index (O-SSI) scoring were done at baseline and after 4 weeks.RESULTS:Twenty-six subjects each received VCO or VOO. Of those on VCO, 20 were positive for SA colonies at baseline versus 12 on VOO. Post intervention, only 1 (5%) VCO subject remained positive versus 6 (50%) of those on VOO. Relative risk for VCO was 0.10, significantly superior to that for VOO (10:1, p  =  .0028; 95% CI, 0.01–0.73); thus, the number needed to treat was 2.2. For the O-SSI, the difference was not significant at baseline (p  =  .15) but was significantly different post treatment (p  =  .004); this was reduced for both oils (p < .005) but was greater with VCO.CONCLUSION:VCO and monolaurin's O-SSI reduction and in vitro broad-spectrum activity against SA (given clinical validity here), fungi, and viruses may be useful in the proactive treatment of AD colonization.
Already A Subscriber?

PubMed Publication LinkOut Login
Username:   
Password:   

Non-Subscriber?

If you are not a current online subscriber to Dermatitis then please click on the link below to purchase the article:

Buy Now!